TABLE 1.
Diversity of samples received in our laboratory and positive samples per year between January 2000 and December 2011
| Year | No. positive/total (%) |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stoolsa | Salivaa | Skin biopsy specimensa | Blooda | Duodenal biopsy specimensa | CSFa | Brain abscessesa | Lymph nodesa | Aqueous humora | Intra-articular fluida | Urinea | Cardiac valvesa | Othersa | Totalb | Patientsc | |
| 2000 | 0/0 (0) | 0/0 (0) | 0/1 (0) | 1/7 (14.29) | 5/54 (9.26) | 0/14 (0) | 0/4 (0) | 1/108 (0.93) | 0/21 (0) | 0/0 (0) | 0/0 (0) | 0/3 (0) | 3/18 (16.67) | 10/230 (4.3) | 10/208 (4.81) |
| 2001 | 0/4 (0) | 0/25 (0) | 0/1 (0) | 0/20 (0) | 3/176 (1.70) | 0/9 (0) | 0/1 (0) | 0/139 (0) | 0/5 (0) | 0/2 (0) | 0/0 (0) | 0/6 (0) | 0/51 (0) | 3/439 (0.68) | 3/368 (0.82) |
| 2002 | 0/1 (0) | 0/5 (0) | 0/1 (0) | 0/49 (0) | 1/61 (1.64) | 0/15 (0) | 0/0 (0) | 0/140 (0) | 0/233 (0) | 0/4 (0) | 0/0 (0) | (18.18) | 2/117 (1.71) | 5/637 (0.78) | 5/526 (0.95) |
| 2003 | 2/23 (8.70) | 3/32 (9.37) | 0/1 (0) | 4/135 (2.96) | 4/77 (5.19) | 11/70 (15.7) | 0/2 (0) | 0/163 (0) | 1/225 (0.44) | 0/2 (0) | 0/0 (0) | 2/4 (50.00) | 12/98 (12.24) | 39/832 (4.69) | 23/597 (3.85) |
| 2004 | 5/86 (5.81) | 4/174 (2.30) | 0/4 (0) | 3/330 (0.90) | 11/135 (8.15) | 11/229 (4.80) | 1/3 (33.3) | 2/195 (1.02) | 3/235 (1.28) | 0/2 (0) | 0/1 (0) | 4/11 (36.36) | 17/170 (10.00) | 61/1,575 (3.87) | 37/777 (4.76) |
| 2005 | 45/168 (26.79) | 8/204 (3.92) | 0/3 (0) | 10/407 (2.46) | 16/175 (9.14) | 9/384 (2.34) | 0/3 (0) | 14/168 (8.33) | 0/158 (0) | 3/10 (30.00) | 1/2 (50.00) | 2/8 (25.00) | 13/139 (9.35) | 121/1,829 (6.62) | 47/818 (5.75) |
| 2006 | 47/250 (18.80) | 12/290 (4.14) | 0/2 (0) | 9/455 (1.98) | 17/204 (8.33) | 13/245 (5.31) | 0/4 (0) | 1/196 (0.51) | 2/255 (0.78) | 0/7 (0) | 0/34 (0) | 7/12 (58.33) | 3/86 (3.49) | 111/2,040 (5.44) | 63/1,130 (5.58) |
| 2007 | 45/267 (16.85) | 24/335 (7.16) | 1/6 (16.67) | 6/472 (1.27) | 15/178 (8.43) | 6/228 (2.63) | 0/2 (0) | 1/240 (0.42) | 0/265 (0) | 3/16 (18.75) | 2/42 (0.83) | 4/20 (20.00) | 9/145 (6.21) | 116/2,216 (5.23) | 50/1,242 (4.03) |
| 2008 | 65/1,207 (5.39) | 20/368 (5.43) | 4/15 (26.67) | 10/581 (1.72) | 13/186 (6.98) | 5/203 (2.46) | 0/8 (0) | 0/253 (0) | 1/145 (0.69) | 1/6 (16.67) | 0/69 (0) | 3/57 (5.26) | 6/144 (4.17) | 128/3,242 (3.95) | 79/1,806 (4.37) |
| 2009 | 128/1,125 (11.37) | 31/691 (4.49) | 6/21 (28.57) | 5/807 (0.62) | 27/273 (9.89) | 8/249 (3.21) | 0/1 (0) | 0/246 (0) | 1/82 (1.22) | 2/23 (8.70) | 1/125 (0.8) | 1/64 (1.56) | 32/283 (11.31) | 242/3,990 (6.07) | 121/2,197 (5.51) |
| 2010 | 74/917 (8.07) | 30/915 (3.38) | 2/8 (25.00) | 4/1,100 (0.36) | 21/312 (6.73) | 5/278 (1.80) | 0/2 (0) | 2/241 (0.83) | 0/72 (0) | 1/48 (2.08) | 1/261 (0.38) | 6/78 (7.69) | 22/372 (5.91) | 168/4,604 (3.65) | 104/2,413 (4.31) |
| 2011 | 121/1,237 (9.78) | 50/1,165 (4.29) | 1/28 (3.57) | 11/1,583 (0.69) | 22/309 (7.12) | 4/261 (1.53) | 1/4 (25.00) | 9/358 (2.51) | 0/269 (0) | 4/114 (3.51) | 1/356 (0.28) | 3/193 (1.55) | 10/412 (2.43) | 237/6,289 (3.77) | 175/3,391 (5.16) |
| Total | 532/5,285 (10.07) | 182/4,204 (4.3) | 14/91 (15.4) | 63/5,946 (1.06) | 155/2,140 (7.24) | 72/2,185 (3.3) | 2/34 (5.9) | 30/2,447 (1.2) | 8/1,965 (0.4) | 14/234 (5.9) | 6/890 (0.7) | 34/467 (7.28) | 129/2,035 (6.3) | 1,241/27,923 (4.44) | 717/15,473 (4.63) |
a
Number of positive samples/total number of samples received (percentage).
b
Total number of positive samples/total number of samples received (percentage).
c
Number of patients with a positive result/total number of patients (percentage).